遺傳檢測市場－全球產業規模、佔有率、趨勢、機會和預測（按疾病類型、按技術、按地區和競爭細分，2020 年至 2030 年）

2024 年全球遺傳檢測市場價值為 65.4 億美元，預計到 2030 年將達到 102.6 億美元，預測期內複合年成長率為 7.79%。遺傳檢測能夠檢測、診斷和預防多種遺傳疾病，這大大改變了現代醫療保健。這個過程也稱為基因或 DNA 檢測，涉及檢查個人的 DNA 以識別與遺傳疾病相關的突變。應用範圍包括診斷囊性纖維化和某些癌症等疾病、指導家庭計劃以及根據個人基因圖譜定製藥物療法。在基因組學和生物技術的快速進步推動下，人們對基因健康的認知不斷提高，並推動其廣泛應用。除了臨床實用性之外，許多消費者還利用遺傳檢測來探索祖先和了解遺傳遺產，促進更廣泛的市場擴張。

關鍵市場促進因素

遺傳疾病盛行率的不斷上升推動了全球遺傳檢測市場的發展

主要市場挑戰

道德和隱私問題

主要市場趨勢

技術進步

目錄

第 1 章：產品概述

第2章：研究方法

第3章：執行摘要

第4章：顧客之聲

第5章：全球基因檢測市場展望

• 市場規模和預測
  • 按價值
• 市場佔有率和預測
  • 依疾病類型（遺傳性癌症檢測、遺傳性非癌症檢測）
  • 依技術（細胞遺傳學、生化、分子檢測）
  • 按地區
  • 按公司分類（2024）
• 市場地圖

第6章：北美基因檢測市場展望

• 市場規模和預測
• 市場佔有率和預測
• 北美：國家分析
  • 美國
  • 加拿大
  • 墨西哥

第7章：歐洲基因檢測市場展望

• 市場規模和預測
• 市場佔有率和預測
• 歐洲：國家分析
  • 德國
  • 英國
  • 義大利
  • 法國
  • 西班牙

第8章：亞太地區基因檢測市場展望

• 市場規模和預測
• 市場佔有率和預測
• 亞太地區：國家分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

第9章：南美洲遺傳檢測市場展望

• 市場規模和預測
• 市場佔有率和預測
• 南美洲：國家分析
  • 巴西
  • 阿根廷
  • 哥倫比亞

第10章：中東與非洲基因檢測市場展望

• 市場規模和預測
• 市場佔有率和預測
• MEA：國家分析
  • 南非
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國

第 11 章：市場動態

• 驅動程式
• 挑戰

第 12 章：市場趨勢與發展

• 合併與收購
• 產品開發
• 最新動態

第 13 章：全球遺傳檢測市場：SWOT 分析

第 14 章：競爭格局

• Myriad Genetics, Inc.
• Illumina, Inc.
• Natera, Inc.
• Laboratory Corporation of America Holdings
• F. Hoffmann-La Roche Ltd.
• Quest Diagnostics Incorporated
• COOPERSURGICAL, INC.
• Agilent Technologies, Inc.
• Thermo Fisher Scientific, Inc.
• SOPHiA GENETICS

第 15 章：策略建議

第16章調查會社について,免責事項

The Global Hereditary Testing Market was valued at USD 6.54 billion in 2024 and is projected to reach USD 10.26 billion by 2030, growing at a CAGR of 7.79% during the forecast period. Hereditary testing has significantly transformed modern healthcare by enabling the detection, diagnosis, and prevention of numerous inherited conditions. Also known as genetic or DNA testing, this process involves examining an individual's DNA to identify mutations linked to hereditary diseases. Applications range from diagnosing conditions like cystic fibrosis and certain cancers to informing family planning and tailoring drug therapies based on individual genetic profiles. The surge in awareness around genetic health, supported by rapid advancements in genomics and biotechnology, is driving widespread adoption. In addition to clinical utility, many consumers are leveraging hereditary testing to explore ancestry and understand genetic heritage, contributing to broader market expansion.

Key Market Drivers

Increasing Prevalence of Genetic Disorders is Driving Global Hereditary Testing Market

The rising incidence of genetic disorders is a primary force behind the growth of the hereditary testing market. As the global population ages, the likelihood of developing hereditary conditions increases, prompting a need for early detection and proactive healthcare. Enhanced research and discovery of genetic markers are broadening the spectrum of diseases for which testing is recommended. Prospective parents are increasingly turning to carrier screening to identify potential hereditary risks to their children, fostering informed reproductive choices. Additionally, genetic testing is gaining traction in assessing susceptibility to hereditary cancers such as breast and colon cancer, enabling timely preventive actions and regular screenings. The expanding understanding of genetics and heightened public awareness are fueling demand for these tests, positioning hereditary testing as a cornerstone of modern personalized medicine.

Key Market Challenges

Ethical and Privacy Concerns

One of the major challenges in the hereditary testing market is the ethical and privacy concerns surrounding genetic data. Individuals are often wary of how their sensitive genetic information is collected, stored, and shared. Risks such as data breaches, unauthorized access, and potential discrimination by employers or insurers create apprehension among users. This has led to increasing calls for stricter data protection laws and transparent policies that ensure confidentiality and responsible usage of genetic information. Addressing these concerns is essential for maintaining public trust and encouraging broader adoption of hereditary testing services.

Key Market Trends

Technological Advancements

The hereditary testing market is being rapidly transformed by technological innovations that are enhancing the speed, affordability, and scope of genetic analysis. One of the most impactful advancements is the widespread adoption of Next-Generation Sequencing (NGS), which allows for efficient and cost-effective sequencing of entire genomes or specific gene panels. This has significantly expanded testing capabilities, making it possible to detect rare mutations and gain deeper insights into genetic predispositions. Additionally, the integration of big data analytics and advanced bioinformatics has revolutionized the interpretation of complex genetic data. These tools enable healthcare providers to identify meaningful patterns and correlations, improving diagnostic accuracy and enabling more precise treatment plans. As these technologies evolve, they are expected to drive further innovation and accessibility in the hereditary testing landscape.

Key Market Players

• Myriad Genetics, Inc.
• Illumina, Inc.
• Natera, Inc.
• Laboratory Corporation of America Holdings
• F. Hoffmann-La Roche Ltd.
• Quest Diagnostics Incorporated
• COOPERSURGICAL, INC.
• Agilent Technologies, Inc.
• Thermo Fisher Scientific, Inc.
• SOPHiA GENETICS

Report Scope:

In this report, the Global Hereditary Testing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Hereditary Testing Market, By Disease Type:

• Hereditary Cancer Testing
• Hereditary Non-cancer Testing

Hereditary Testing Market, By Technology:

• Cytogenetic
• Biochemical
• Molecular Testing

Hereditary Testing Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Hereditary Testing Market.

Available Customizations:

Global Hereditary Testing market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

4. Voice of Customer

5. Global Hereditary Testing Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Disease Type (Hereditary Cancer Testing, Hereditary Non-cancer Testing)
  • 5.2.2. By Technology (Cytogenetic, Biochemical, Molecular Testing)
  • 5.2.3. By Region
  • 5.2.4. By Company (2024)
• 5.3. Market Map

6. North America Hereditary Testing Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Disease Type
  • 6.2.2. By Technology
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Hereditary Testing Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Disease Type
      • 6.3.1.2.2. By Technology
  • 6.3.2. Canada Hereditary Testing Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Disease Type
      • 6.3.2.2.2. By Technology
  • 6.3.3. Mexico Hereditary Testing Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Disease Type
      • 6.3.3.2.2. By Technology

7. Europe Hereditary Testing Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Disease Type
  • 7.2.2. By Technology
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Hereditary Testing Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Disease Type
      • 7.3.1.2.2. By Technology
  • 7.3.2. United Kingdom Hereditary Testing Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Disease Type
      • 7.3.2.2.2. By Technology
  • 7.3.3. Italy Hereditary Testing Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Disease Type
      • 7.3.3.2.2. By Technology
  • 7.3.4. France Hereditary Testing Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Disease Type
      • 7.3.4.2.2. By Technology
  • 7.3.5. Spain Hereditary Testing Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Disease Type
      • 7.3.5.2.2. By Technology

8. Asia-Pacific Hereditary Testing Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Disease Type
  • 8.2.2. By Technology
  • 8.2.3. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Hereditary Testing Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Disease Type
      • 8.3.1.2.2. By Technology
  • 8.3.2. India Hereditary Testing Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Disease Type
      • 8.3.2.2.2. By Technology
  • 8.3.3. Japan Hereditary Testing Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Disease Type
      • 8.3.3.2.2. By Technology
  • 8.3.4. South Korea Hereditary Testing Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Disease Type
      • 8.3.4.2.2. By Technology
  • 8.3.5. Australia Hereditary Testing Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Disease Type
      • 8.3.5.2.2. By Technology

9. South America Hereditary Testing Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Disease Type
  • 9.2.2. By Technology
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Hereditary Testing Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Disease Type
      • 9.3.1.2.2. By Technology
  • 9.3.2. Argentina Hereditary Testing Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Disease Type
      • 9.3.2.2.2. By Technology
  • 9.3.3. Colombia Hereditary Testing Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Disease Type
      • 9.3.3.2.2. By Technology

10. Middle East and Africa Hereditary Testing Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Disease Type
  • 10.2.2. By Technology
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Hereditary Testing Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Disease Type
      • 10.3.1.2.2. By Technology
  • 10.3.2. Saudi Arabia Hereditary Testing Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Disease Type
      • 10.3.2.2.2. By Technology
  • 10.3.3. UAE Hereditary Testing Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Disease Type
      • 10.3.3.2.2. By Technology

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition
• 12.2. Product Development
• 12.3. Recent Developments

13. Global Hereditary Testing Market: SWOT Analysis

14. Competitive Landscape

• 14.1. Myriad Genetics, Inc.
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Financials (As Reported)
  • 14.1.5. Recent Developments
  • 14.1.6. Key Personnel Details
  • 14.1.7. SWOT Analysis
• 14.2. Illumina, Inc.
• 14.3. Natera, Inc.
• 14.4. Laboratory Corporation of America Holdings
• 14.5. F. Hoffmann-La Roche Ltd.
• 14.6. Quest Diagnostics Incorporated
• 14.7. COOPERSURGICAL, INC.
• 14.8. Agilent Technologies, Inc.
• 14.9. Thermo Fisher Scientific, Inc.
• 14.10. SOPHiA GENETICS

15. Strategic Recommendations

16. About Us & Disclaimer